Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7903)
All Articles published online
|
Publishing Process of This Article
|
Dec 28, 2018 (publication date) through May 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ahmed M. Checkpoint inhibitors: What gastroenterologists need to know. World J Gastroenterol 2018; 24(48): 5433-5438 [PMID: 30622372 DOI: 10.3748/wjg.v24.i48.5433] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i48/5433.htm |
| Number | Citing Articles |
| 1 |
Julie R Brahmer, Hamzah Abu-Sbeih, Paolo Antonio Ascierto, Jill Brufsky, Laura C Cappelli, Frank B Cortazar, David E Gerber, Lamya Hamad, Eric Hansen, Douglas B Johnson, Mario E Lacouture, Gregory A Masters, Jarushka Naidoo, Michele Nanni, Miguel-Angel Perales, Igor Puzanov, Bianca D Santomasso, Satish P Shanbhag, Rajeev Sharma, Dimitra Skondra, Jeffrey A Sosman, Michelle Turner, Marc S Ernstoff. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events. Journal for ImmunoTherapy of Cancer 2021; 9(6): e002435 doi: 10.1136/jitc-2021-002435
|
| 2 |
Hiroyuki Suzuki, Hideki Iwamoto, Shigeo Shimose, Takashi Niizeki, Tomotake Shirono, Yu Noda, Naoki Kamachi, Taizo Yamaguchi, Masahito Nakano, Ryoko Kuromatsu, Hironori Koga, Takumi Kawaguchi. Case Report: Exacerbation of varices following atezolizumab plus bevacizumab treatment of hepatocellular carcinoma: A case series and literature review. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.948293
|
| 3 |
Ze Xu, Guanpeng Qi, Xin Liu, Zhaohang Li, Aijun Zhang, Juman Ma, Zuojing Li, Sai-Ching Jim Yeung. Hepatotoxicity in immune checkpoint inhibitors: A pharmacovigilance study from 2014–2021. PLOS ONE 2023; 18(3): e0281983 doi: 10.1371/journal.pone.0281983
|
| 4 |
Stephen D. H. Malnick, Ali Abdullah, Manuela G. Neuman. Checkpoint Inhibitors and Hepatotoxicity. Biomedicines 2021; 9(2): 101 doi: 10.3390/biomedicines9020101
|
| 5 |
Nicole Gri, Yaroslava Longhitano, Christian Zanza, Valentina Monticone, Damiano Fuschi, Andrea Piccioni, Abdelouahab Bellou, Ciro Esposito, Iride Francesca Ceresa, Gabriele Savioli. Acute Oncologic Complications: Clinical–Therapeutic Management in Critical Care and Emergency Departments. Current Oncology 2023; 30(8): 7315 doi: 10.3390/curroncol30080531
|
| 6 |
Biruh T. Workeneh, Nupur N. Uppal, Kenar D. Jhaveri, Helbert Rondon-Berrios. Hypomagnesemia in the Cancer Patient. Kidney360 2021; 2(1): 154 doi: 10.34067/KID.0005622020
|
| 7 |
Anusha Bapatla, Tooba Tariq, Maryam Bilal Haider, Bashar Mohamad. Atezolizumab, a PD-L1 Inhibitor: An Association of Bleeding Gastric Ulcer With Its Use. Cureus 2021; doi: 10.7759/cureus.15637
|
| 8 |
Carolin Lechmann, Konrad Streetz. Leitsymptom Übelkeit, Erbrechen, Verstopfung, Durchfall in der Notaufnahme. Notaufnahme up2date 2023; 5(02): 145 doi: 10.1055/a-1542-5023
|
| 9 |
Rocio Sedano, Daniel Cabrera, Andrea Jiménez, Christopher Ma, Vipul Jairath, Marco Arrese, Juan Pablo Arab. Immunotherapy for Cancer: Common Gastrointestinal, Liver, and Pancreatic Side Effects and Their Management. American Journal of Gastroenterology 2022; 117(12): 1917 doi: 10.14309/ajg.0000000000001983
|
| 10 |
Kateřina Šašková. Therapeutic possibilities of selected gastrointestinal complications in oncology patients. Onkologie 2022; 16(2): 91 doi: 10.36290/xon.2022.018
|
| 11 |
Kathleen M. Capaccione, Jacienta P. Valiplackal, Alice Huang, Tina Roa, Alana Fruauff, Connie Liou, Eleanor Kim, Sakshi Khurana, Mary Maher, Hong Ma, Pamela Ngyuen, Serena Mak, Shifali Dumeer, Sonali Lala, Belinda D'souza, Sherelle Laifer-Narin, Elise Desperito, Carrie Ruzal-Shapiro, Mary M. Salvatore. Checkpoint Inhibitor Immune-Related Adverse Events: A Multimodality Pictorial Review. Academic Radiology 2022; 29(12): 1869 doi: 10.1016/j.acra.2022.03.007
|
| 12 |
Jing Chen, Yaser Alduais, Baoan Chen. Therapeutic and Systemic Adverse Events of Immune Checkpoint Inhibitors Targeting the PD-1/PD-L1 axis for Clinical Management of NSCLC. Cell Transplantation 2021; 30: 096368972110415 doi: 10.1177/09636897211041587
|
| 13 |
Itunu Owoyemi, Lisa E. Vaughan, Collin M. Costello, Charat Thongprayoon, Svetomir N. Markovic, Joerg Herrmann, Clark C. Otley, Timucin Taner, Aaron R. Mangold, Nelson Leung, Sandra M. Herrmann, Aleksandra Kukla. Clinical outcomes of solid organ transplant recipients with metastatic cancers who are treated with immune checkpoint inhibitors: A single‐center analysis. Cancer 2020; 126(21): 4780 doi: 10.1002/cncr.33134
|
| 14 |
Himesh B. Zaver, Hassan M. Ghoz, William C. Palmer. 31-Year-Old Woman With Diarrhea. Mayo Clinic Proceedings 2021; 96(1): e1 doi: 10.1016/j.mayocp.2020.05.050
|